PT  - JOURNAL ARTICLE
AU  - Lachmann, Alexander
TI  - Correcting under-reported COVID-19 case numbers
AID  - 10.1101/2020.03.14.20036178
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.14.20036178
4099  - http://medrxiv.org/content/early/2020/03/18/2020.03.14.20036178.short
4100  - http://medrxiv.org/content/early/2020/03/18/2020.03.14.20036178.full
AB  - The COVID-19 virus has spread worldwide in a matter of a few month. Healthcare systems struggle to monitor and report current cases. Limited capabilities in testing result in difficult to guide policies and mitigate lack of preparation. Since severe cases, which more likely lead to fatal outcomes, are detected at a higher percentage than mild cases, the reported death rates are likely inflated in most countries. Such under-estimation can be attributed to under-sampling of infection cases and results in systematic death rate estimation biases.The method proposed here utilizes a benchmark country (South Korea) and its reported death rates in combination with population demographics to correct the reported COVID-19 case numbers. By applying a correction, we predict that the number of cases is highly under-reported in most countries. In the case of China, it is estimated that more than 700.000 cases of COVID-19 actually occurred instead of the confirmed 80,932 cases as of 3/13/2020.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data is available on the Kaggle platform. https://www.kaggle.com/lachmann12/correcting-under-reported-covid-19-case-numbers